E L Saenko

Factor VIII C2 Domain Contains the Thrombin-binding Site Responsible for Thrombin-catalyzed Cleavage at Arg1689 *

T. Koide, K. Nogami, M. Shima, 2000, The Journal of Biological Chemistry.

Factor V C2 domain contains a major thrombin‐binding site responsible for thrombin‐catalyzed factor V activation

K. Nogami, M. Shima, A. Yoshioka, 2006, Journal of thrombosis and haemostasis : JTH.

Cell Surface Heparan Sulfate Proteoglycans Participate in Factor VIII Catabolism Mediated by Low Density Lipoprotein Receptor-related Protein*

M. Shima, M Shima, E. Saenko, 2001, The Journal of Biological Chemistry.

Stable recombinant expression and characterization of the two haemophilic factor VIII variants C329S (CRM−) and G1948D (CRMr)

E. Tuddenham, J. McVey, D. David, 2001, British journal of haematology.

Mathematical models of blood coagulation and platelet adhesion: clinical applications.

M. Panteleev, F. Ataullakhanov, F I Ataullakhanov, 2007, Current pharmaceutical design.

The inhibitor antibody response is more complex in hemophilia A patients than in most nonhemophiliacs with factor VIII autoantibodies. Recombinate and Kogenate Study Groups.

I. Scharrer, G. Bray, I. Nilsson, 1997, Blood.